697 results
APPROCHE DÉDIÉE À LA PRESTATION DES SERVICES DE VACCINATION CONTRE LA COVID-19 DE LA ZAMBIE: UTILISER LA GÉNÉRATION DE DEMANDE ASCENDANTE POUR ATTEINDRE CHAQUE PERSONNE ADMISSIBLE
UTILISATION D’UNE APPROCHE SANS INCINÉRATION POUR LA GESTION DES DÉCHETS CONTAMINÉS (OBJETS POINTUS ET TRANCHANTS) GÉNÉRÉS PAR LA VACCINATION CONTRE LA COVID-19 DANS LA VALLÉE DE KATMANDOU
UTILISATION D’UNE APPROCHE SANS INCINÉRATION POUR LA GESTION DES DÉCHETS CONTAMINÉS (OBJETS POINTUS ET TRANCHANTS) GÉNÉRÉS PAR LA VACCINATION CONTRE LA COVID-19 DANS LA VALLÉE DE KATMANDOU
This is the presentation of the sixth session of the 'Learning Collective Initiative’ in Covid 19 Vaccine Delivery Partnership (CoVDP) webinar series.
Estas recomendaciones provisionales1 se refieren a la vacuna mRNA-1273, fabricada por Moderna, que también se conoce como vacuna anti-COVID-19 de Moderna. En algunos países la vacuna se...
This short case study illustrates how India successfully leveraged
its existing digital data solutions as part of its COVID-19 vaccination
response. It outlines the solutions used by the country...
SAFE MANAGEMENT OF THE HAZARDOUS WASTE GENERATED AND STORED AS RESIDUAL WASTE IN THE VACCINE CENTERS OF KATHMANDU VALLEY DURING COVID-19 VACCINATION CAMPAIGN
This is the presentation of the fifth session of the 'Learning Collective Initiative’ in Covid 19 Vaccine Delivery Partnership (CoVDP) webinar series.
This job aid provides guidance on safe and effective management and disposal of wastes generated by COVID-19 vaccination activities at the facility level. It reminds health workers and wastes...
People living with HIV depend on life-saving antiretroviral therapy (ART) and access to ART must be maintained during periods of travel restrictions and lockdowns resulting from the COVID-19...
Recommandations provisoires concernant l’utilisation du vaccin de Valneva (VLA2001) contre la COVID-19 : orientations provisoires, première publication : 18 août 2022
Recomendaciones provisionales sobre el uso de la vacuna BNT162b2 de Pfizer y BioNTech contra la COVID-19 en el marco de la Lista OMS de uso en emergencias: orientaciones provisionales, primera...
Urgent actions needed to close gaps in the global COVID-19 response
This Findings Report includes an overview of the MOMENTUM Routine Immunization Transformation and Equity project’s global mapping of private sector interventions supporting COVID-19 efforts,...
The vaccine tracker was developed by World Bank in an effort to identify countries in urgent need of financial and operational support for vaccine deployment readiness, and to monitor, track and...
This is a link to a set of posts on vaccine introduction, supply chain and storage planning, and communication with communities,This is a link to a set of posts on vaccine introduction, supply chain...
This is a link to a post on trainings and competencies healthcare professionals need to administer vaccines safely to recipients,This is a link to a post on trainings and competencies healthcare...
This is a link to a post on how to generate demand for Covid-19 vaccination,This is a link to a post on how to generate demand for Covid-19 vaccination
This link is to a blog post on learning from Covid-19 and use of data to improve health systems ,This link is to a blog post on learning from Covid-19 and use of data to improve health systems
This is a link to the regional fact sheets on Covid-19 response,This is a link to the regional fact sheets on Covid-19 response
This is Rockefeller microsite on Covid-19 vaccine particularly focusing on increasing demand and accelerating global equity,This is Rockefeller microsite on Covid-19 vaccine particularly focusing on...
This is a blog post on training approaches for health workers to deliver vaccines focusing on digital training,This is a blog post on training approaches for health workers to deliver vaccines...
A post on ensuring equitable vaccination in lower income countries. The post highlights key areas including strengthening data systems, supporting immunization supply chain improvements and driving...
A microsite on past sessions and recordings of forums and webinars that capture lessons learnt from the response of the pandemic.,A microsite on past sessions and recordings of forums and webinars...
A compilation of resources and experiences on COVID-19,A compilation of resources and experiences on COVID-19
Series of brief reports on Covid-19 vaccine development, allocation and deployment particularly covering principles of for vaccine allocation, strategies for deployment and delivery of COVID-19...
This link provides country feature stories on Covid-19 vaccination,This link provides country feature stories on Covid-19 vaccination
The page provides ways of tacking vaccine inequity by promoting demand for immunization through social listening. It also provides other resources relevant to the topic,The page provides ways of...
Analyse de la réponse du pays à la COVID-19 et identification des meilleures pratiques et des lacunes cruciales à prendre en compte dans les futurs plans d’intervention,Analyse de la réponse du...
During this fourth session, we hear directly from Malawi and Sierra Leone on their experiences of developing their One Plan One Budget for their COVID-19 vaccination programme. The counties share...
The Learning Agenda team works with all Vaccine sub-pillars, West, Central and South East Africa partners and other external partners to ensure lessons are well documented and immediately shared to...
Maldives_Joint Covid-19 cPIE and HPV PIE,Maldives_Joint Covid-19 cPIE and HPV PIE
A systematic review of COVID-19 vaccine roll-out experiences and lessons learned is being undertaken by the World Health Organization (WHO), the U.S. Agency for International Development (USAID)...
The mini c-PIE reports of 15 low- and middle-income countries (LMICs) from five of the six WHO regions were included in the review. They were selected based on availability, willingness to share, and...
Niger_Rapport RIA Vaccination COVID-19 (IAR),Niger_Rapport RIA Vaccination COVID-19 (IAR)
This good practice statement has been developed based on the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 11 August 2022.
These are the annexes to the Interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19.
This background document was prepared by the Strategic Advisory Group of Experts (SAGE) on Immunization Working Group on COVID-19 vaccines to inform the discussions of SAGE for Valneva vaccine...
This interim recommendation pertains to the COVID-19 Valneva vaccine (VLA2001), developed by Valneva’s research and development teams in France and Austria with the marketing authorization holder,...
This session is the 3rd in our series on Strategies for optimizing Covid-19 vaccine distribution.
Cette session est la deuxième session de notre série de webinaires sur les Stratégies d'optimisation de la distribution des vaccins contre la COVID-19.
Description: Cette session explorera la...
This session will explore the verification and traceability of COVID-19 vaccines. There will be a review of the current efforts and perspectives on labeling of vaccines, followed by a presentation of...
This session will explore the verification and traceability of COVID-19 vaccines. There will be a review of the current efforts and perspectives on labeling of vaccines, followed by a presentation of...
Cette session est la première session de notre série de webinaires sur les Stratégies d'optimisation de la distribution des vaccins contre la COVID-19
Description: Pour maximiser les avantages...
To maximize the benefits of COVID-19 vaccine deployment for all, it is important to identify and address the gender-related barriers that impact access to health services, including immunization....
To maximize the benefits of COVID-19 vaccine deployment for all, it is important to identify and address the gender-related barriers that impact access to health services, including immunization....
This is the presentation of the third session of the 'Learning Collective Initiative’ in Covid 19 Vaccine Delivery Partnership (CoVDP) webinar series.
Ceci est la quatrième session de notre série webinaire sur les Stratégies d'optimisation de la distribution des vaccins contre la COVID-19.
Description: L'un des principaux défis auxquels les...
This is the 4th session in our webinar series on Strategies for optimizing Covid-19 vaccine distribution.
Description: One of the major challenges countries are facing during the COVID-19 vaccine...
This is the 4th session in our webinar series on Strategies for optimizing Covid-19 vaccine distribution.
Description: One of the major challenges countries are facing during the COVID-19 vaccine...
This session is the 3rd in our series on Strategies for optimizing Covid-19 vaccine distribution.
Cette session est la troisième session de notre série de webinaires sur les Stratégies d'optimisation de la distribution des vaccins contre la COVID-19.
This session is the 3rd in our series on Strategies for optimizing Covid-19 vaccine distribution.
Tool to help countries using COVID vaccination coverage and surveillance data to determine a crude vaccine effectiveness
This is the presentation of the second session of the 'Learning Collective Initiative’ in Covid 19 Vaccine Delivery Partnership ( CoVDP) webinar series.
There is a lack of comprehensive and systematic data and evidence regarding the effectiveness of mandatory and incentive-based vaccination schemes. The results of such programs in some countries have...
The WHO website provides a list of certain diseases for which vaccines are available, and a list of some pathogens for which vaccines and/or monoclonal antibodies (mAbs) are in development. For each...
The webinar will orient countries on the new Pfizer BioNTech COVID-19 Vaccine new Tris/Sucrose formulation. The objective is to support countries transition to use the new vaccine formulation, with...
Pfizer BioNTech COVID-19 Nouvelle formulation du vaccin : incidences sur la gestion des vaccins, la chaîne d'approvisionnement et l'assistance technique
Annexes to the recommendations for use of the CanSinoBIO Ad5-nCoV-S [recombinant] vaccine (Convidecia™) against COVID-19: grading of evidence: evidence to recommendation tables, first...
Interim recommendations for use of the CanSinoBIO Ad5-nCoV-S [recombinant] vaccine (Convidecia™) against COVID-19: interim guidance, first issued 19 May 2022
Background document to the WHO interim recommendations for use of the CanSinoBIO Ad5-nCoV-S vaccine (ConvideciaTM) against COVID-19, issued 19 May 2022
This document is a UPS presentation made during a webinar session on "Pfizer BioNTech COVID-19 Vaccine new formulation: implications on vaccine management, supply chain, and technical assistance".
Vaccine management processes are designed to ensure product quality and comprises an integrated system of equipment, procedures, records, and activities. Effective vaccine management requires that...
This COVID-19 Maternal Immunization Resource Library is a central place to host links to global and country-specific research and data, guidance, tools, publications, and other resources related to...
Présentation de Crown Agents lors de la session webinaire sur : Nouvelle formulation du vaccin COVID-19 de Pfizer BioNTech : implications sur la gestion des vaccins, la chaîne d'approvisionnement...
Presentation from Crown Agents during the webinar session on: Pfizer BioNTech COVID-19 Vaccine new formulation: implications on vaccine management, supply chain, and technical assistance
This Q&A compiles questions asked during the 3 sessions of the webinar on: Pfizer BioNTech COVID-19 Vaccine new formulation: implications on vaccine management, supply chain, and technical...
The webinar oriented countries on the new Pfizer BioNTech COVID-19 Vaccine new Tris/Sucrose formulation. The objective is to support countries transition to use the new vaccine formulation, with...
Le webinaire orientera les pays sur la nouvelle formulation Tris/Sucrose du vaccin COVID-19 de Pfizer BioNTech. L'objectif est de soutenir les pays en transition vers l'utilisation de la nouvelle...
The Consortium aims to deliver a more sustainable, efficent, and transparent approach to generating disease burden and vaccine impact estimates. It works on aggregating the estimates across a...
Les questions et réponses présentées ici se basent sur les recommandations provisoires les plus récentes du Groupe stratégique consultatif d’experts sur la vaccination (SAGE) de l’OMS...
COVID-19 vaccine delivery has begun in many low- and middle- income countries (LMICs) and many countries will be looking to scale as more vaccines arrive. The distribution of COVID-19 vaccines is...
This document serves to update the policy brief Injection safety in the context of coronavirus disease (COVID-19) vaccination (IS Policy Brief), with additional guidance. The IS Policy Brief remains...
The COVID-19 pandemic has decreased uptake of pediatric preventive care, including immunizations. This study estimates the prevalence of missed pediatric routine medical visits and vaccinations over...
Cette note technique offre aux pays des considérations opérationnelles sur le choix d'une stratégie de distribution appropriée pour promouvoir la vaccination contre COVID-19.
Les présentes orientations provisoires ont été élaborées sur la base de l’avis émis par le Groupe stratégique consultatif d’experts (SAGE) sur la vaccination lors de sa réunion...
Les présentes orientations provisoires ont été élaborées sur la base de l’avis émis par le Groupe stratégique consultatif d’experts (SAGE) sur la vaccination lors de sa réunion...
Les présentes orientations provisoires ont été élaborées sur la base de l’avis émis par le Groupe stratégique consultatif d’experts (SAGE) sur la vaccination lors de sa réunion...
Pandemi Covid-19 sangat memengaruhi pelayanan imunisasi di seluruh dunia. Tenaga kesehatan dialihkan untuk
pelayanan Covid-19 dan orangtua merasa takut membawa anaknya untuk imunisasi ke fasilitas...
Contenido: En esta presentación se resumen las recomendaciones y consideraciones más recientes de la OMS para elegir productos vacunales contra la COVID-19 con la lista de la OMS para uso de...
Organisation mondiale de la Santé. (2022). Recommandations provisoires pour l’utilisation du vaccin anti-COVID-19 inactivé, CoronaVac, développé par Sinovac : orientations provisoires,...
Оперативное руководство по созданию системы ультрахолодовой цепи в рамках подготовки к внедрению вакцины...
This guidance is focused on establishing and managing a UCC system. It provides practical guidance to support countries in planning and selecting the appropriate UCC system design and equipment based...
This guidance is focused on establishing and managing a UCC system. It provides practical guidance to support countries in planning and selecting the appropriate UCC system design and equipment based...
This guidance is focused on establishing and managing a UCC system. It provides practical guidance to support countries in planning and selecting the appropriate UCC system design and equipment based...
This guidance is focused on establishing and managing a UCC system. It provides practical guidance to support countries in planning and selecting the appropriate UCC system design and equipment based...
Contenu : Ce jeu de diapositives résume les derniers facteurs à prendre en considération et recommandations de l’OMS quant au choix des produits vaccinaux contre la COVID-19 avec la liste...
Los sistemas de gestión de datos son fundamentales para proporcionar visibilidad a los datos logísticos de extremo a extremo, pero sólo si "hablan" entre sí. Durante esta sesión, exploraremos...
Edición OpenLMIS COVID para apoyar las cadenas de suministro durante COVID (16ª Conferencia TechNet)
Edición OpenLMIS (Sistema de información de gestión logística abierta) COVID para apoyar las cadenas de suministro durante COVID
En esta sesión se investigarán las formas en que los programas nacionales de inmunización pueden llegar a determinados grupos objetivo de la vacuna Covid-19, como los trabajadores sanitarios y los...
La pandemia de COVID-19 ha proporcionado a los países los retos pero también las oportunidades de innovar para coordinar mejor las cadenas de suministro de inmunización nacionales y subnacionales...
Content: This slide set summarizes WHO latest recommendations and considerations for choosing COVID-19 vaccine products with WHO Emergency Use List (EUL) (currently available under COVAX) as of 18...
Les systèmes de gestion des données sont essentiels pour assurer la visibilité des données logistiques de bout en bout, mais seulement s'ils se "parlent" entre eux. Au cours de cette session,...
La visibilité finale des données logistiques est un facteur clé pour assurer la disponibilité des produits pour nos communautés. Au cours de cette session, nous examinerons la dernière édition...